Soluble CD163 from activated macrophages predicts mortality in acute liver failure. - Wikidata - wikimedia - TriplyDB

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

http://www.wikidata.org/entity/Q36333669

about

Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure.Clinical significance of sCD163 and its possible role in asthma (Review).Inhibition of 5-lipoxygenase pathway attenuates acute liver failure by inhibiting macrophage activation A new treatment strategy for acute liver failure.The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.Soluble CD163, a product of monocyte/macrophage activation, is inversely associated with haemoglobin levels in placental malaria.Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure.Cirrhosis patients have increased risk of complications after hip or knee arthroplasty Immune mediated liver failure.Effects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2 Expression of serum sCD163 in patients with liver diseases and inflammatory disorders.Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure.Functional role of monocytes and macrophages for the inflammatory response in acute liver injury.Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure.The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids.A high prevalence of extreme hyperferritinemia in acute hepatitis patients.Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy.Neurological management of fulminant hepatic failure.Systematic review: acute liver failure - one disease, more than 40 definitions.Alcoholic hepatitis: The pivotal role of Kupffer cells.Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.Low-grade elevation of fibrinogen-degradation products is an important parameter to identify acute presentation of autoimmune hepatitis.The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.Outcome analysis of hip or knee arthroplasty in patients with cirrhotic liver disease.The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.Impaired monocyte-macrophage functions and defective Toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure.Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.Role of monocytes and macrophages in experimental and human acute liver failure.Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients.Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients.The macrophage activation product sCD163 is associated with a less favourable metabolic profile in prepubertal children.Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.Circulating Levels of the Shed Scavenger Receptor sCD163 and Association with Outcome of Critically Ill Patients High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study

P2860

Q33586759-10C1F126-6F96-49A3-892C-B8C4C115D3CF Q33674640-24773DE2-6D04-4513-9666-995E771D1706 Q33759028-9A01065E-6A57-454A-866F-C88764374384 Q34415338-B65CA840-AF2D-438E-95E5-A95F666A2E4D Q34652179-7D0DAC9C-18A8-4DD3-95DF-3FD0CCD189B3 Q34745250-7728A374-9EDD-4D5D-8B05-C3BD0578C6DD Q35085251-68EE38FC-528A-4D2E-A356-8D2FBE81ED07 Q35197633-D336388D-4B7D-40D6-9726-A997E5C77378 Q35729249-D61A2107-F8AD-47F4-B914-68E2CD43453E Q35741156-8C4DA1D9-0528-4576-858D-55A9596C1AF9 Q36014427-5694F67F-2919-43C2-A75F-DAD943EF8ABC Q36230503-B1528E33-1092-428F-8D88-AB8CA98EB9E9 Q36331567-454907F2-CBD5-4E00-9002-810429E77C43 Q36841343-B9DF9C6C-7496-4974-8C62-041473194284 Q37358244-13A05A2E-3943-42C9-B6D7-74B00701260D Q37579180-3703B4EB-32C5-484F-92AD-7241A932550A Q37729056-1C2B11B1-CC97-4199-BCBD-EE6F3189EABF Q37815043-4713C4A6-D693-439A-8FCA-54F4A395C7CD Q38002880-EFF7D950-D704-40C2-B64E-0D89B7839A72 Q38645785-ED3F0C13-EF9F-4C10-852B-E2644AAE3A85 Q38675714-7AEA610F-6C01-4AE2-B777-F9CE1E6B3FC8 Q39780824-17A5C84C-8050-4A55-AEFB-07B2F1521F02 Q40337789-2F2E122D-37E1-4C01-9C23-F91F779D382E Q40378611-587CE772-E3C3-4283-BA8C-15C4DAF0D5E7 Q40495697-9DB6851D-3B22-4946-A411-6AC2FCEB3BB7 Q40734458-BAC0BC3C-B890-45BB-A165-CD49DACEAECD Q41020103-227F27ED-CB02-4D39-80AD-D536C3E974D3 Q41757581-8479695C-A3FF-4ACC-A6F5-1ADFE0B673EA Q42231930-474A946C-CB56-4AA5-98D3-2CEDC1CD1BFB Q42232930-48B4E0FD-066C-4E95-8CB8-DFEE047FE40F Q42834819-020F7BBF-2263-414E-B513-924EF1DBC6CC Q44322514-69FEC4B1-49C7-4292-9D2C-415035474301 Q46048010-5A7F46E0-71FF-4DA6-B795-037E5AB42CAB Q46898742-B5142298-EC14-49F5-8D5D-50604DE6EB69 Q47896040-4E65AF25-017D-48B7-8E8B-CE45A9700D0C Q47993022-F5B38E59-E4B1-440A-A407-03BC3D0EFA70 Q52873745-44662BAD-E752-48C9-8E8D-5E226A99E5E3 Q57245093-BE4BFD7F-C387-433D-9526-0E15F7503E7F Q58706878-45B8FB1B-A534-44C4-A437-947FA549022F

P2860

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

http://www.wikidata.org/entity/Q36333669

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

@ast

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

@en

type

label

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

@ast

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

@en

prefLabel

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

@ast

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

@en

P1433

Q36333669-7DA3BFCB-8B3A-46FA-8314-B178CEE254D8

P1476

Q36333669-137A6A75-98E9-4050-8213-B871D322F5FB

P2093

Q36333669-021D16FB-872F-4DB2-8E05-3CEB4A6226C0

Q36333669-0D4CFC04-ED78-4E40-98BA-9680E7C0C638

Q36333669-21971F07-A7BA-4C81-BF4B-67023DE74975

Q36333669-8006CB4F-4148-41D4-A6BE-A4951D7CE03C

Q36333669-9B74C86C-8CFC-431C-AE82-589E060D2D2D

Q36333669-A61EAC36-8D88-43B9-BBC1-685579017186

Q36333669-DA9AE114-3C35-44DA-9E89-A1C5CB3758E4

Q36333669-DFECBDDF-B2DE-4781-8C02-4C9A40302E93

Q36333669-FCA42B02-C2EF-4942-8C1E-3C9F7962ABC5

P2860

Q36333669-055D6125-790E-47B9-99C1-A574F00FC22B

Q36333669-160BF683-2B55-4225-B8C5-7797F302B9AA

Q36333669-33402791-3405-4F92-87BB-0CA8CE9FF226

Q36333669-3907F5CC-1CDD-4739-9950-545209260FD5

Q36333669-42669A10-7FD0-447B-82E0-AF1DC90C7EE8

Q36333669-45A4D025-C036-47E5-9D8C-25771850FB50

Q36333669-897204A0-2EDA-46E0-9D92-12E44A5013AE

Q36333669-8DDB5118-C108-4F06-9ECD-086592AE3DAF

Q36333669-9E1D740D-E37E-4D72-868B-DA209F06BA65

Q36333669-9FFB5D34-F85C-44E9-9E2B-CAA01F33EBC4

P304

Q36333669-B598299F-CB3B-4E60-8810-39641C59C1FA

P31

Q36333669-99E48221-BBCF-46C3-8526-5F011D1EC29D

P356

Q36333669-00FF34BA-440C-4656-90F1-2885C3428B10

P433

Q36333669-3EE19E08-2A43-4193-AFEA-E06016A7107B

P478

Q36333669-A4FDEE11-3C81-4592-8896-C67BE00074A2

P577

Q36333669-A21161F8-EFA4-4A4B-8E4E-3FA3D6A568AE

P5875

Q36333669-C63210E1-0ED6-45DD-986B-21B0F073C2B3

P698

Q36333669-ECBA846A-7047-4B74-ADF4-F02899F49979

P921

Q36333669-16F3B337-6DEE-4E47-AD3B-D6D1F12272B4

P932

Q36333669-99D31277-22D3-41DC-A952-DC4CA68F247D

P356

J.JHEP.2007.05.014

P1433

Journal of Hepatology

P1476

Soluble CD163 from activated macrophages predicts mortality in acute liver failure.

@en

P2093

Frank V Schiødt

http://www.w3.org/2001/XMLSchema#string

Henning Grønbaek

http://www.w3.org/2001/XMLSchema#string

Holger Jon Møller

http://www.w3.org/2001/XMLSchema#string

Michael Schilsky

http://www.w3.org/2001/XMLSchema#string

Peter Holland-Fischer

http://www.w3.org/2001/XMLSchema#string

Santiago Munoz

http://www.w3.org/2001/XMLSchema#string

Tarek Hassanein

http://www.w3.org/2001/XMLSchema#string

U.S. Acute Liver Failure Study Group

http://www.w3.org/2001/XMLSchema#string

William M Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Early indicators of prognosis in fulminant hepatic failure

Expression of CD163 in the liver of patients with viral hepatitis

The meaning and use of the area under a receiver operating characteristic (ROC) curve

The many faces of macrophage activation

Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family.

Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.

Identification of the haemoglobin scavenger receptor.

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response.

Biochemical and functional characterization of three activated macrophage populations.

P304

671-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2007.05.014

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6207811

http://www.w3.org/2001/XMLSchema#string

P698

17629586

http://www.w3.org/2001/XMLSchema#string

P921

P932

2179895

http://www.w3.org/2001/XMLSchema#string